4/A

FORM 4/A SUBMISSION

Company: Larimar Therapeutics, Inc.
Filed: October 20, 2015
Period of Report: September 15, 2015
Accession Number: 0000899243-15-006924

View Document ↗ View on SEC.gov ↗